An MRI radiomics model for predicting a prostate-specific antigen response following abiraterone treatment in patients with metastatic castration-resistant prostate cancer

An MRI radiomics model for predicting a prostate-specific antigen response following abiraterone treatment in patients with metastatic castration-resistant prostate cancer

ObjectiveTo establish a combined radiomics-clinical model for the early prediction of a prostate-specific antigen(PSA) response in patients with metastatic castration-resistant prostate cancer(mCRPC) after treatment with abiraterone acetate(AA).MethodsThe data of a total of 60 mCRPC patients from tw...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yi Wu, Xiang Liu, Shaoxian Chen, Fen Fang, Feng Shi, Yuwei Xia, Zehong Yang, Daiying Lin
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Oncology
Subjects:	neoplasms (prostate) biparametric MRI radiomics model abiraterone metastatic castration-resistant prostate cancer
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1491848/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Meta-analysis to evaluate the comparative effectiveness of enzalutamide and abiraterone acetate for first-line treatment of metastatic castration-resistant prostate cancer in real-world settings
by: Armen Aprikian, et al.
Published: (2025-02-01)

Clinical observations of patients with metastatic castration-resistant prostate cancer living in the Tambov region
by: P. G. Berezin, et al.
Published: (2023-09-01)

The correlation between the expression of androgen receptor splice variant-7 (AR-V7) protein with the time of occurrence of castration-resistant prostate cancer and overall survival in prostate cancer in Indonesian population
by: Indrawarman Soerohardjo, et al.
Published: (2025-02-01)

RADIUM-223. PLACE IN THE TREATMENT OF METASTATIC CASTRATION-REFRACTORY PROSTATE CANCER
by: A. A. Kostin, et al.
Published: (2017-12-01)

Generation of Whole-Genome Sequencing Data for Comparing Primary and Castration-Resistant Prostate Cancer
by: Jong-Lyul Park, et al.
Published: (2018-09-01)

Microbially produced imidazole propionate impairs prostate cancer progression through PDZK1
by: Shengkai Jin, et al.
Published: (2025-01-01)

Repeatability, reproducibility, and the effects of radiotherapy on radiomic features of lowfield MR-LINAC images of the prostate
by: Parker Anderson, et al.
Published: (2025-01-01)

Biomarkers in metastatic castration-resistant prostate cancer for efficiency of immune checkpoint inhibitors
by: Zixi Wu, et al.
Published: (2025-12-01)

Personalized optimization of systematic prostate biopsy core number based on mpMRI radiomics features: a large-sample retrospective analysis
by: Zhenlin Chen, et al.
Published: (2025-01-01)

Development and Validation of an MRI‐Based Radiomics Nomogram to Predict the Prognosis of De Novo Oligometastatic Prostate Cancer Patients
by: Wen‐Qi Liu, et al.
Published: (2024-12-01)

Analysis of the predictive value of the prostate-specific antigen-to-neutrophil ratio for the diagnosis of prostate cancer
by: Yuxuan Chen, et al.
Published: (2025-01-01)

Incidence of prostate adenocarcinoma in transurethral resection of the prostate patients
by: Yahia Ghazwani, et al.
Published: (2025-01-01)

A novel peptide encoded by circSRCAP confers resistance to enzalutamide by inhibiting the ubiquitin-dependent degradation of AR-V7 in castration-resistant prostate cancer
by: Xiannan Meng, et al.
Published: (2025-01-01)

External beam radiation therapy versus radical prostatectomy for high-risk prostate cancer: protocol of the RECOVER study
by: Caroline M. van der Starre, et al.
Published: (2025-01-01)

Value of Systematic and MRI‐Ultrasound Fusion Prostate Biopsy in Different Prostate Specific Antigen (PSA) Levels
by: Solmaz Ohadian Moghadam, et al.
Published: (2025-01-01)

The Novel Histological Prostatic Inflammation Score Helps Defining the Association Between Stromal and Glandular Inflammation with the Risk of Prostate Cancer at Prostate Biopsy
by: Ugo Giovanni Falagario, et al.
Published: (2025-01-01)

SleepNow – A combined cognitive behavioral therapy for insomnia and physical exercise intervention in men with metastatic prostate cancer: results from a feasibility randomized controlled trial
by: Beverley Lim Høeg, et al.
Published: (2025-02-01)

Current biomarkers of prostate cancer
by: I. A. Aboian, et al.
Published: (2021-12-01)

Use of erectile dysfunction treatments after prostate cancer treatment and their perceived impact on men’s sex life: an analysis of patient reported outcome survey data
by: Megan Charlick, et al.
Published: (2025-01-01)

Sideroflexin family genes were dysregulated and associated with tumor progression in prostate cancers
by: Hua Huang, et al.
Published: (2025-02-01)

Prostate Cancer Stereotactic Body Radiation Therapy with Image-guided Radiation Therapy (IGRT) Technique with Three-Dimensional Transperineal Ultrasound for IGRT Tracking of the Prostate
by: Igor Migowski, et al.
Published: (2025-01-01)

Investigating the Expression of c-Myc and BIRC5 in TRAIL and PBOX-15 treated Metastatic Prostate Cancer Cells
by: Corinne Kai Leng Chew, et al.
Published: (2024-12-01)

Comparative Study of Gleason 7 (3+4) and (4+3) Prostatic Adenocarcinomas with Prognostic Criteria and Immunohistochemical Profiles of AMACR, PSA and Ki-67
by: Clarice F. E. M. Osório, et al.
Published: (2025-01-01)

A case of stromal sarcoma of the prostate with the incidental detection of prostate adenocarcinoma
by: Shang Xu, et al.
Published: (2025-03-01)

Meta-analyses of mouse and human prostate single-cell transcriptomes reveal widespread epithelial plasticity in tissue regression, regeneration, and cancer
by: Luis Aparicio, et al.
Published: (2025-01-01)

The factors impacting on Gleason score upgrading in prostate cancer with initial low Gleason scores
by: Tzu-Heng Huang, et al.
Published: (2025-02-01)

Inhibiting HnRNP L-mediated alternative splicing of EIF4G1 counteracts immune checkpoint blockade resistance in Castration-resistant prostate Cancer
by: Xumin Zhou, et al.
Published: (2025-02-01)

Magnetic Resonance Imaging Techniques for Post-Treatment Evaluation After External Beam Radiation Therapy of Prostate Cancer: Narrative Review
by: Eleni Bekou, et al.
Published: (2024-12-01)

Diagnostic Accuracy of Serum Prostate Specific Antigen and Gleason Score in Determining the Presence of Skeletal Metastasis in Prostate Cancer Patients: a Pakistani Perspective
by: Taimoor Nasir, et al.
Published: (2023-04-01)

Comparison of intensity normalization methods in prostate, brain, and breast cancer multi-parametric magnetic resonance imaging
by: Savannah R. Duenweg, et al.
Published: (2025-02-01)

Prostatic Artery Embolization: A Systematic Review Article
by: Pooja Atkuri, et al.
Published: (2025-01-01)

Correlation of clinically significant prostate cancer sites across multiparametric MRI, prostate biopsy, and whole-mount pathology for optimal prostate biopsy strategy
by: Matteo Pacini, et al.
Published: (2025-02-01)

A Rare Metastasis of Prostate Cancer
by: İlkin Hamid-Zada, et al.
Published: (2024-07-01)

Prostate Cancer Screening: Is it Recommended in 2024?
by: Dr. Ali Thwaini
Published: (2024-12-01)

Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the Prostate
by: Edgar Linden-Castro, et al.
Published: (2014-01-01)

Transition zone-based prostate-specific antigen density for differentiating clinically significant prostate cancer in PI-RADS score 3 lesions
by: Yongming Jin, et al.
Published: (2025-01-01)

Circular RNA circBNC2 inhibits tumorigenesis by modulating ferroptosis and acts as a nanotherapeutic target in prostate cancer
by: Xiang Pan, et al.
Published: (2025-01-01)

The “prostate-pelvic syndrome” theory used in patients with type-III prostatitis and its correlation with prostate volume
by: Xiao-Ma Zhang, et al.
Published: (2025-01-01)

Monitoring of prostate-specific antigen in men with benign prostate enlargement receiving 5-alpha reductase inhibitors: a non-interventional, cross-sectional study of real-world practice of urologists in Spain and Brazil
by: Juan Manuel Palacios, et al.
Published: (2025-01-01)

Malondialdehyde in benign prostate hypertrophy: a useful marker?
by: Rosaria Alba Merendino, et al.
Published: (2003-01-01)